Cargando…
A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer
TP53 and FGFR3 mutations are the most common mutations in bladder cancers. FGFR3 mutations are most frequent in low-grade low-stage tumours, whereas TP53 mutations are most frequent in high-grade high-stage tumours. Several studies have reported FGFR3 and TP53 mutations to be mutually exclusive even...
Autores principales: | Neuzillet, Yann, Paoletti, Xavier, Ouerhani, Slah, Mongiat-Artus, Pierre, Soliman, Hany, de The, Hugues, Sibony, Mathilde, Denoux, Yves, Molinie, Vincent, Herault, Aurélie, Lepage, May-Linda, Maille, Pascale, Renou, Audrey, Vordos, Dimitri, Abbou, Claude-Clément, Bakkar, Ashraf, Asselain, Bernard, Kourda, Nadia, El Gaaied, Amel, Leroy, Karen, Laplanche, Agnès, Benhamou, Simone, Lebret, Thierry, Allory, Yves, Radvanyi, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521761/ https://www.ncbi.nlm.nih.gov/pubmed/23272046 http://dx.doi.org/10.1371/journal.pone.0048993 |
Ejemplares similares
-
A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
por: Vallot, Céline, et al.
Publicado: (2011) -
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015) -
A prospective multicenter study on bladder cancer: the COBLAnCE cohort
por: Benhamou, Simone, et al.
Publicado: (2016) -
Deregulation of Rab and Rab Effector Genes in Bladder Cancer
por: Ho, Joel R., et al.
Publicado: (2012) -
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score
por: Simon, Marie, et al.
Publicado: (2019)